Paul Murphy

Chief Biomedical Scientist
THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST

Presentation(s):

• PB0301 - Multi-centre performance evaluation of ADAMTS13 activity quantification using three different measurement technologies

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0304 - Low ADAMTS13 activity rapid assay results in patients with low clinical probability of Thrombotic Thrombocytopaenic Purpura (TTP) – the United Kingdom experience

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0305 - Method and laboratory specific clinical cut-offs support appropriate interpretation of ADAMTS13 activity assays

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM